Cargando…

Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer

This manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to use neoadjuvant chemotherapy in triple negative breast cancer patients.

Detalles Bibliográficos
Autores principales:	Bhattacharyya, G. S., Walia, M., Nandi, M., Murli, A., Salim, S., Rajpurohit, S., Shinde, S., Aggarwal, S., Parikh, P. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909296/ https://www.ncbi.nlm.nih.gov/pubmed/29721485 http://dx.doi.org/10.4103/sajc.sajc_126_18

Ejemplares similares

Practical consensus recommendations on ovarian suppression in early breast cancer (adjuvant)
por: Singhal, M., et al.
Publicado: (2018)

Practical consensus recommendations on management of triple-negative metastatic breast cancer
por: Rangarao, R., et al.
Publicado: (2018)

Genetic variations in triple-negative breast cancers undergoing neo-adjuvant chemotherapy
por: Mori, Miki, et al.
Publicado: (2019)

Practical consensus recommendations on duration of adjuvant hormonal therapy in breast cancer
por: Gupta, S., et al.
Publicado: (2018)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer
por: Bansal, GJ, et al.
Publicado: (2015)

Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer
por: Basade, M., et al.
Publicado: (2018)

Practical consensus recommendations for gestational breast cancer
por: Sekhon, J. S., et al.
Publicado: (2018)

Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis
por: Bianco, Nadia, et al.
Publicado: (2021)

Practical consensus recommendation on when to do BRCA testing
por: Parikh, Purvish M., et al.
Publicado: (2018)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer compared to other subtypes of breast cancer
por: Bansal, Gaurav J, et al.
Publicado: (2016)

Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer
por: Tang, Yiqing, et al.
Publicado: (2012)

[(18)F]FDG and [(18)F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer
por: Raccagni, Isabella, et al.
Publicado: (2018)

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
por: Lluch, Ana, et al.
Publicado: (2020)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer
por: Horimoto, Yoshiya, et al.
Publicado: (2014)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
por: Findlay, John M., et al.
Publicado: (2016)

Practical consensus recommendaton for adjuvant bone-modifying agents in breast cancer
por: Bharatuar, A., et al.
Publicado: (2018)

Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy
por: Song, Wu, et al.
Publicado: (2012)

Practical consensus recommendations on fertility preservation in patients with breast cancer
por: Bajpai, Jyoti, et al.
Publicado: (2018)

Practical consensus recommendations regarding role of postmastectomy radiation therapy
por: Singh, D., et al.
Publicado: (2018)

Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling
por: Aggarwal, S., et al.
Publicado: (2018)

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy
por: Giacchetti, Sylvie, et al.
Publicado: (2022)

Practical consensus recommendations for tumor margins and breast conservative surgery
por: Sarin, R., et al.
Publicado: (2018)

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
por: Drooger, Jan C., et al.
Publicado: (2016)

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
por: Mousavi, Seyyed AsadoLah, et al.
Publicado: (2013)

Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
por: Xi, Xun, et al.
Publicado: (2022)

Effectiveness of adjuvant chemotherapy for elderly patients with triple-negative breast cancer
por: Guo, Qiusheng, et al.
Publicado: (2023)

Practical consensus recommendations regarding the management of sentinel lymph node issues in early breast cancer
por: Kabra, Vedant, et al.
Publicado: (2018)

Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India
por: Parikh, Purvish M., et al.
Publicado: (2021)

Prognostic Value of Stromal Tumor-Infiltrating Lymphocytes in Young, Node-Negative, Triple-Negative Breast Cancer Patients Who Did Not Receive (neo)Adjuvant Systemic Therapy
por: de Jong, Vincent M.T., et al.
Publicado: (2022)

Practical consensus recommendations regarding the use of hormonal therapy in metastatic breast cancer
por: Rajappa, Senthil, et al.
Publicado: (2018)

Phase II study of neo-adjuvant chemotherapy for locally advanced gastric cancer
por: Chang, Alex Yuang-Chi, et al.
Publicado: (2016)

Neo-adjuvant chemotherapy in stage IIIC potentially resectable epithelial ovarian cancer
por: Voutsadakis, Ioannis A.
Publicado: (2016)

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study
por: Constantinidou, Anastasia, et al.
Publicado: (2020)

Impact of oncoplasty in increasing breast conservation rates Post neo-adjuvant chemotherapy
por: Koppiker, Chaitanyanand B., et al.
Publicado: (2023)

Changes in leukoencephalopathy and serum neurofilament after (neo)adjuvant chemotherapy for breast cancer
por: Schroyen, Gwen, et al.
Publicado: (2023)

Practical consensus recommendations on Her2 +ve breast cancer with solitary brain mets
por: Rohatgi, Nitesh, et al.
Publicado: (2018)

Practical consensus recommendations regarding role of mastectomy in metastatic breast cancer
por: Somsekhar, S. P., et al.
Publicado: (2018)

Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer
por: Bahl, A., et al.
Publicado: (2018)

High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
por: Vliek, Sonja, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cu4uoc47jl0hdbfrpq36s31fm1